[1]李继霞 黄宝生.糖尿病患者使用碘对比剂安全性循证评价[J].介入放射学杂志,2009,(08):636.
　LI Ji-xia HUANG Bao-sheng.The evidence-based evaluation of the safety of contrast media in patients with diabetes mellitus[J].journal interventional radiology,2009,(08):636.

点击复制

糖尿病患者使用碘对比剂安全性循证评价()

PDF下载中关闭

• 
• 
• 

分享到：

参考文献/References:

1.Gleeson TG.Bulugahapitiya S Contrast-induced nephropathy 2004
2.Rao QA.Newhouse JH Risk of nephropathy after intravenous administration of contrast material:a critical literature analysisl 2006
3.滕皋军 对比剂肾病:介入手术必须重视的并发症 [期刊论文] -介入放射学杂志2008
4.Guyatt GH.Rennie D The Evidence-Based Medicine Working Group.Users' Guides to the Medical Literature:A Mannual for Evidence-based Practice 2002
5.Phillips B.Ball C.Sackett D Levels of evidence and grades of recommendation 6.Rudnick MR.Goldfarb S.Wexler L Nephrotoxicity of ionic and nonionie contrast media in 1196 patients:a randomized trial.The Iohexol Cooperative Study 1995
7.中华医学会放射学分会.中国医师协会放射医师分会 对比剂使用指南 [期刊论文] -中华放射学杂志2008
8.Nguyen SA.Suranyi P.Ravenel JG lso-esmolality versus low-esmolality iodinated contrast medium at intravenous contrastenhanced CT:effect on kidney function 2008
9.Solomon R.Dumouchel W Contrast media and nephropathy:findings from systematic analysis and Food and Drug Administration reports of adverse effects 2006
10.Sharma SK.Kini A Effect of nonionic radioeontrast agents on the occurrence of contrast-induced nephropathy in patients with mild-moderate chronic renal insufficiency:pooled analysis of the randomized trials 2005
11.Heinrich MC.Haberle L.Miiller V Nephrotoxicity of isoosmolar iodixanol compared with nonionic low--osmolar contrast media:meta-analysis of randomized controlled trials 2009
12.McCullough PA.Bertrand ME.Brinker JA A Metaanalysis of the renal safety of isosmolar iodixanol compared with low-osmolar contrast media 2006
13.Aspelin P.Aubry P.Fransson SG Nephrotoxie effects in high-risk patients undergoing angiog raphy 2003
14.Aspelin P.Aubry P.Fransson SG Cost-effectiveness of iodixanol in patients at high risk of contrast-induced nephropathy 2005
15.Jo SH.Youn TJ.Koo BK Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography:the RECOVER study:a randomized controlled trial 2006
16.Kuhn MJ.Chen N.Sahani DV The PREDICT study:a randomized double-blind comparison of contrast-induced nephropathy after low-or isoosmolar contrast agent exposure 2008
17.Barrett BJ.Katzberg RW.Thomsen HS Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed tomography:a double-blind comparison of iodixanol and iopamidol 2006